Coloplast Inks $2.5B Med Biz Deal With Linklaters-Led PE Firm
By Charlie Innis (November 8, 2021, 7:38 PM EST) -- Danish medtech developer Coloplast said Monday it plans to buy Atos Medical for about €2.16B (roughly $2.5 billion) from global private equity firm PAI Partners, with guidance from Kromann Reumert and Linklaters LLP.
The deal to buy Atos Medical, a Swedish company making medical devices for people who've undergone laryngectomy surgery, would bring Coloplast A/S access to a new chronic care business, according to a company announcement.
Coloplast creates products to improve quality-of-life conditions for people who live with an ostomy bag or are treated for bladder and bowel issues. The Danish company said it will operate Atos Medical as a...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!